PECA Labs

Pittsburgh, United States Founded: 2011 • Age: 15 yrs
Pediatric cardiac surgical devices are developed for congenital heart defects.
Request Access

About PECA Labs

PECA Labs is a company based in Pittsburgh (United States) founded in 2011.. PECA Labs has raised $22.56 million across 12 funding rounds from investors including HHS, Innovation Works and BlueTree Allied Angels. PECA Labs offers products and services including exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH. PECA Labs operates in a competitive market with competitors including Xeltis, Occlutech, Endonovo Therapeutics, Bolder Surgical and Coherex, among others.

  • Headquarter Pittsburgh, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Peca Labs, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $22.56 M (USD)

    in 12 rounds

  • Latest Funding Round
    $2.65 M (USD), Series B

    Nov 06, 2025

  • Investors
    HHS

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PECA Labs

PECA Labs offers a comprehensive portfolio of products and services, including exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides next-generation grafts with radiopaque features for advanced visualization.

Offers customizable, expandable grafts for improved anatomical matching.

Delivers anti-thrombogenic grafts with bio-inert surfaces to reduce complications.

Features polymeric conduit for pulmonary reconstruction in clinical trials.

Includes transcatheter valve with slim delivery for enhanced performance.

People of PECA Labs
Headcount 1-10
Employee Profiles 5
Employee Profiles
People
Arush Kalra
Co-Founder/Chief Scientific Officer
People
Blue Martin, PhD
Senior Research Engineer
People
Jamie Quinterno
Co-Founder and Chief Operating Officer
People
Dharani A.
Regulatory Affairs Specialist

Unlock access to complete

Funding Insights of PECA Labs

PECA Labs has successfully raised a total of $22.56M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $2.65 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 12
  • Last Round Series B — $2.7M
  • First Round

    (06 Aug 2013)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2025 Amount Series B - PECA Labs Valuation

investors

Dec, 2024 Amount Series B - PECA Labs Valuation

investors

Nov, 2022 Amount Debt – Conventional - PECA Labs Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PECA Labs

PECA Labs has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Innovation Works and BlueTree Allied Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Software, hardware, and life sciences startups are funded and accelerated.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PECA Labs

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PECA Labs

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Peca Labs Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PECA Labs

PECA Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Xeltis, Occlutech, Endonovo Therapeutics, Bolder Surgical and Coherex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of bioabsorbable synthetic heart valves and vascular grafts
domain founded_year HQ Location
Provider of minimally invasive cardiac devices for congenital heart defects, stroke prevention and heart failure
domain founded_year HQ Location
Bioelectronic devices are developed for regenerative medicine therapies.
domain founded_year HQ Location
Developer of electrosurgical device for pediatric patients
domain founded_year HQ Location
Structural heart disease conditions are addressed with implant devices.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Peca Labs

Frequently Asked Questions about PECA Labs

When was PECA Labs founded?

PECA Labs was founded in 2011 and raised its 1st funding round 2 years after it was founded.

Where is PECA Labs located?

PECA Labs is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.

Is PECA Labs a funded company?

PECA Labs is a funded company, having raised a total of $22.56M across 12 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $618.18K, raised on Aug 06, 2013.

What does PECA Labs do?

PECA Labs was founded in 2011 and is based in Pittsburgh, United States. Focus is placed on the medical device sector, specifically pediatric cardiology. Operations involve the creation of synthetic valved conduits, such as the MASA valve made from ePTFE for right ventricular outflow tract reconstruction. A valved RV-PA shunt is also under development to treat hypoplastic left heart syndrome and mitigate risks associated with the Norwood Procedure.

Who are the top competitors of PECA Labs?

PECA Labs's top competitors include Xeltis, Bolder Surgical and Endonovo Therapeutics.

What products or services does PECA Labs offer?

PECA Labs offers exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH.

Who are PECA Labs's investors?

PECA Labs has 3 investors. Key investors include HHS, Innovation Works, and BlueTree Allied Angels.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available